Benzinga's Top Upgrades, Downgrades For February 23, 2017

Top Upgrades

• Analysts at Morgan Stanley upgraded Home Depot Inc HD from Equal-Weight to Overweight. Home Depot shares rose 0.74 percent to $146.33 in pre-market trading.
• UBS upgraded International Flavors & Fragrances Inc IFF from Neutral to Buy. International Flavors shares rose 0.83 percent to close at $122.63 on Wednesday.
• Analysts at Jefferies upgraded ONEOK, Inc. OKE from Underperform to Hold. ONEOK shares fell 1.29 percent to close at $53.52 on Wednesday.
• Analysts at Piper Jaffray upgraded Steven Madden, Ltd. SHOO from Neutral to Overweight. Steven Madden shares rose 2.81 percent to $38.30 in pre-market trading.
• Analysts at Compass Point upgraded Patriot National Inc PN from Neutral to Buy. Patriot National shares fell 4.30 percent to close at $4.45 on Wednesday.
• Analysts at Argus Research upgraded Roper Technologies Inc ROP from Hold to Buy. Roper Technologies shares rose 0.24 percent to close at $207.87 on Wednesday.
• BTIG Research upgraded Square Inc SQ from Neutral to Buy. Square shares gained 9.8 percent to $16.51 in pre-market trading.
• Raymond James upgraded AquaVenture Holdings Ltd WAAS from Outperform to Strong Buy. AquaVenture Holdings shares gained 2.72 percent to $18.50 in pre-market trading.
• Longbow Research upgraded Restaurant Brands International Inc QSR from Underperform to Neutral. Restaurant Brands shares dropped 2.76 percent to close at $56.01 on Wednesday.

Top Downgrades

• Moffett Nathanson downgraded Charter Communications, Inc. CHTR from Buy to Neutral. Charter Communications shares closed at $325.14 on Wednesday.
• Nomura downgraded NVIDIA Corporation NVDA from Buy to Reduce. NVIDIA shares fell 4.30 percent to $106.00 in pre-market trading.
• Wells Fargo downgraded Reynolds American, Inc. RAI from Outperform to Market Perform. Reynolds American shares rose 0.56 percent to $61.29 in pre-market trading.
• Credit Suisse downgraded Bloomin' Brands Inc BLMN from Outperform to Neutral. Bloomin Brands shares dropped 4.99 percent to close at $17.88 on Wednesday.
• FBR Capital downgraded Dorman Products Inc. DORM from Outperform to Market Perform. Dorman Products shares rose 7.86 percent to close at $77.94 on Wednesday.
• Barclays downgraded Nationstar Mortgage Holdings Inc NSM from Equal-Weight to Underweight. Nationstar Mortgage shares rose 1.46 percent to close at $18.79 on Wednesday.
• Update: This article originally said analysts at Wells Fargo downgraded Juno Therapeutics Inc JUNO from Outperform to Market Perform. This is incorrect; On Wednesday, Wells Fargo initiated Juno at Outperform.
• Analysts at Stifel Nicolaus downgraded La-Z-Boy Incorporated LZB from Buy to Hold. La-Z-Boy shares fell 1.41 percent to $28.00 in pre-market trading.
• Imperial Capital downgraded FLIR Systems, Inc. FLIR from Outperform to In-Line. FLIR Systems shares dropped 0.22 percent to close at $36.68 on Wednesday.
• Analysts at Needham downgraded Argos Therapeutics Inc ARGS from Buy to Hold. Argos Therapeutics shares gained 1.69 percent to $1.50 in pre-market trading.

Top Initiations

• Analysts at Noble Financial initiated coverage on DLH Holdings Corp. DLHC with a Buy rating. The price target for DLH Holdings is set to $7.50. DLH Holdings shares closed at $5.27 on Wednesday.
• Analysts at Janney Capital initiated coverage on Global Medical REIT Inc GMRE with a Buy rating. Global Medical REIT shares closed at $8.48 on Wednesday.
• Analysts at Morgan Stanley initiated coverage on IMPINJ Inc PI with an Overweight rating. IMPINJ shares closed at $28.49 on Wednesday.
• Analysts at Craig-Hallum initiated coverage on Sevcon Inc SEV with a Buy rating. The price target for Sevcon is set to $24. Sevcon shares closed at $14.00 on Wednesday.
• Analysts at Stifel Nicolaus initiated coverage of Reata Pharmaceuticals Inc RETA with a Buy rating. Reata Pharmaceuticals shares closed at $23.21 on Wednesday.
• Analysts at RBC Capital initiated coverage on Monsanto Company MON with a Sector Perform rating. The price target for Monsanto is set to $118. Monsanto shares closed at $111.38 on Wednesday.
• Analysts at Chardan Capital initiated coverage of OncoCyte Corp OCX with a Buy rating. The price target for OncoCyte is set to $6.50. OncoCyte shares closed at $5.05 on Wednesday.
• Analysts at Goldman Sachs initiated coverage on Jeld-Wen Holding Inc JELD with a Neutral rating. The price target for Jeld-Wen Holding is set to $28. Jeld-Wen shares closed at $30.70 on Wednesday.
• Evercore ISI Group initiated coverage on Jazz Pharmaceuticals plc JAZZ with a Buy rating. Jazz Pharmaceuticals shares closed at $134.95 on Wednesday.
• RBC Capital initiated coverage on Albemarle Corporation ALB with an Outperform rating. The price target for Albemarle is set to $114. Albemarle shares closed at $92.44 on Wednesday.